Fingerprint
Dive into the research topics where Hang Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Article
-
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
Shi, F., He, Z., Wang, L., Su, H. & Han, S., 18 Oct 2022, In: Frontiers in Pharmacology. 13Research output: Contribution to journal › Article › peer-review
Open Access -
Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Shi, F., He, Z., Su, H., Wang, L. & Han, S., 16 Nov 2022, In: Frontiers in Pharmacology. 13Research output: Contribution to journal › Article › peer-review
Open Access
Activities
- 1 Types of Public engagement and outreach - Festival/Exhibition
-
Public engagement in health economics: CHEME at the Bangor Science Festival.
Pijeira Perez, Y. (Contributor), Culeddu, G. (Contributor), Su, H. (Contributor) & Holmes, E. (Contributor)
9 Mar 2024Activity: Other › Types of Public engagement and outreach - Festival/Exhibition